India
Haematology · 4 min read

Primary familial and congenital erythrocytosis

Learn about Primary familial and congenital erythrocytosis, its reported features, relevant specialists, and questions to discuss at a medical consultation.

Also known as: PFCE; PFCP; Primary familial and congenital erythrocytosis due to erythropoietin receptor mutation; Primary familial and congenital polycythemia; Primary familial and congenital polycythemia due to erythropoietin receptor mutation; Primary hereditary and congenital erythrocytosis

and 3 more Primary hereditary and congenital erythrocytosis due to erythropoietin receptor mutation; Primary hereditary and congenital polycythemia; Primary hereditary and congenital polycythemia due to erythropoietin receptor mutation

Compiled from public sources
Text selected and arranged from Orphanet. It describes the condition as those sources do; it has not been rewritten for India.
01 Oct 2026
Not medically reviewed
No registered doctor has reviewed this page. Use it to decide who to see and what to ask — not to diagnose or treat.
—
This is not medical advice. If symptoms are severe, sudden or getting worse, call 112 (or 108 for an ambulance) or go to the nearest emergency department.

The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.

What it is

From: Orphanet

Primary familial polycythemia is an inherited hematological disorder resulting from mutations in the erythropoietin (EPO) receptor and is characterized by an elevated absolute red blood cell mass caused by uncontrolled red blood cell production in the presence of low EPO levels.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal hemoglobin · Very frequent (99-80%)
Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes.
Dyspnea · Very frequent (99-80%)
Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.
Epistaxis · Very frequent (99-80%)
Epistaxis, or nosebleed, refers to a hemorrhage localized in the nose.
Fatigue · Very frequent (99-80%)
A subjective feeling of tiredness characterized by a lack of energy and motivation.
Headache · Very frequent (99-80%)
Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.
Polycythemia · Very frequent (99-80%)
Polycythemia is diagnosed if the red blood cell count, the hemoglobin level, and the red blood cell volume all exceed the upper limits of normal.
Venous thrombosis · Very frequent (99-80%)
Formation of a blood clot (thrombus) inside a vein, causing the obstruction of blood flow.
Vertigo · Very frequent (99-80%)
An abnormal sensation of spinning while the body is actually stationary.
Abdominal pain · Frequent (79-30%)
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the abdomen.
Arthralgia · Frequent (79-30%)
Joint pain.
Pruritus · Frequent (79-30%)
Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.
Abnormal bleeding · Occasional (29-5%)
An abnormal susceptibility to bleeding, often referred to as a bleeding diathesis. A bleeding diathesis may be related to vascular, platelet and coagulation defects.
Cough · Occasional (29-5%)
A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation.
Exertional dyspnea · Occasional (29-5%)
Perceived difficulty to breathe that occurs with exercise or exertion and improves with rest.

Other findings in the same source

From: Orphanet

Additional reported features include Thromboembolism (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

All ages

Inheritance in the source

From: Orphanet

Autosomal dominant

Understanding the inheritance label

From: MedlinePlus Genetics

An autosomal dominant pattern means that one altered copy of a relevant gene can be sufficient for the condition. Some affected people inherit the change; others have a new change without an affected parent. The precise finding, family history and condition determine what this means for relatives.

Which doctor should you see?

The suggested department for discussing Primary familial and congenital erythrocytosis is Haematology, with a haematologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

  • Which blood-cell, marrow, bleeding or clotting finding matters most?
  • Does the diagnosis need confirmation or a more precise subtype?
  • Which symptoms or laboratory changes should trigger earlier review?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Primary familial and congenital erythrocytosis. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.

Find a doctor for Primary familial and congenital erythrocytosis

This condition is usually assessed by a haematologist. Every profile shows the doctor’s registration and what has been checked.

All haematology conditions →

Sources

Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.

General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1928.